LEADER 03877nam 2200589Ia 450 001 9910144115103321 005 20170815111041.0 010 $a1-281-93950-1 010 $a9786611939502 010 $a0-470-71399-2 010 $a0-470-71400-X 035 $a(CKB)1000000000549641 035 $a(EBL)366803 035 $a(OCoLC)298944318 035 $a(SSID)ssj0000258339 035 $a(PQKBManifestationID)11224002 035 $a(PQKBTitleCode)TC0000258339 035 $a(PQKBWorkID)10256870 035 $a(PQKB)11559297 035 $a(MiAaPQ)EBC366803 035 $a(EXLCZ)991000000000549641 100 $a20080520d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aTherapeutics of Parkinson's disease and other movement disorders$b[electronic resource] /$fedited by Mark Hallett and Werner Poewe 210 $aChichester, West Sussex, UK ;$aHoboken, NJ $cWiley-Blackwell$d2008 215 $a1 online resource (519 p.) 300 $aDescription based upon print version of record. 311 $a0-470-06648-2 320 $aIncludes bibliographical references and index. 327 $aTHERAPEUTICS of PARKINSON'S DISEASE and OTHER MOVEMENT DISORDERS; Contents; Preface; Contributors; PART I PARKINSON'S DISEASE AND PARKINSONISM; 1 The Etiopathogenesis of Parkinson's Disease: Basic Mechanisms of Neurodegeneration; 2 Physiology of Parkinson's Disease; 3 Pharmacology of Parkinson's Disease; 4 The Treatment of Early Parkinson's Disease; 5 Treatment of Motor Complications in Advanced Parkinson's Disease; 6 Managing the Non-Motor Symptoms of Parkinson's Disease; 7 Surgery for Parkinson's Disease; 8 Future Cell- and Gene-Based Therapies for Parkinson's Disease 327 $a9 Parkinson-Plus DisordersPART II TREMOR DISORDERS; 10 Essential Tremor; 11 Other Tremor Disorders; PART III DYSTONIA, CRAMPS, AND SPASMS; 12 Pathophysiology of Dystonia; 13 General Management Approach to Dystonia; 14 Botulinum Toxin for Treatment of Dystonia; 15 Surgical Treatments of Dystonia; 16 Wilson's Disease; 17 Cramps and Spasms; 18 Stiff Person Syndrome; PART IV CHOREA, TICS AND OTHER MOVEMENT DISORDERS; 19 Huntington's Disease; 20 Chorea; 21 Treatment of Tics and Tourette Syndrome; 22 Therapeutics of Paroxysmal Dyskinesias; 23 Treatment of Miscellaneous Disorders; 24 Myoclonus 327 $aPART V DRUG-INDUCED MOVEMENT DISORDERS25 Neuroleptic-Induced Movement Disorders; 26 Other Drug-Induced Dyskinesias; PART VI ATAXIA AND DISORDERS OF GAIT AND BALANCE; 27 Ataxia; 28 Treatment of Gait and Balance Disorders; PART VII RESTLESS LEGS SYNDROME; 29 The Restless Legs Syndrome; PART VIII PEDIATRIC MOVEMENT DISORDERS; 30 Pediatric Movement Disorders; PART IX PSYCHOGENIC MOVEMENT DISORDERS; 31 Psychogenic Movement Disorders; Index 330 $aProvides a comprehensive update on therapies for Parkinson's disease and other movement disordersDescribes the basic mechanisms of neurodegeneration, pharmacologic interventions for motor and non-motor symptoms, and surgical managementFeatures summary tables and algorithms that serve as a quick reference guide for practical treatment decisionsThe expert guidance of recognised authorities will enable readers of this book to plan their patients' care with greater confidence 606 $aParkinson's disease$xTreatment 606 $aMovement disorders$xTreatment 608 $aElectronic books. 615 0$aParkinson's disease$xTreatment. 615 0$aMovement disorders$xTreatment. 676 $a616.83306 701 $aHallett$b Mark$f1943-$0883419 701 $aPoewe$b W$0924229 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910144115103321 996 $aTherapeutics of Parkinson's disease and other movement disorders$92074091 997 $aUNINA